418 related articles for article (PubMed ID: 20675971)
1. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
Uguz F
Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
[No Abstract] [Full Text] [Related]
3. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
4. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
Womersley K; Ripullone K; Agius M
Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843
[TBL] [Abstract][Full Text] [Related]
5. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
[TBL] [Abstract][Full Text] [Related]
6. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.
Reefhuis J; Devine O; Friedman JM; Louik C; Honein MA;
BMJ; 2015 Jul; 351():h3190. PubMed ID: 26156519
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
8. Neonatal complications after intrauterine exposure to SSRI antidepressants.
Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
Kulin NA; Pastuszak A; Sage SR; Schick-Boschetto B; Spivey G; Feldkamp M; Ormond K; Matsui D; Stein-Schechman AK; Cook L; Brochu J; Rieder M; Koren G
JAMA; 1998 Feb; 279(8):609-10. PubMed ID: 9486756
[TBL] [Abstract][Full Text] [Related]
11. [The transfer of selective serotonin reuptake inhibitors to human milk].
Nordeng H; Bergsholm YK; Bøhler E; Spigset O
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
[TBL] [Abstract][Full Text] [Related]
12. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
13. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Moore ML; Eichner SF; Jones JR
Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
[TBL] [Abstract][Full Text] [Related]
14. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.
Yazdy MM; Mitchell AA; Louik C; Werler MM
Epidemiology; 2014 Nov; 25(6):859-65. PubMed ID: 25171134
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
[TBL] [Abstract][Full Text] [Related]
16. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
Kemp AH; Fráguas R; Brunoni AR; Bittencourt MS; Nunes MA; Dantas EM; Andreão RV; Mill JG; Ribeiro AL; Koenig J; Thayer JF; Benseñor IM; Lotufo PA
Psychosom Med; 2016 Sep; 78(7):810-8. PubMed ID: 27219492
[TBL] [Abstract][Full Text] [Related]
17. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Assimon MM; Brookhart MA; Flythe JE
J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
[TBL] [Abstract][Full Text] [Related]
18. Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
Guo S; Chen L; Cheng S; Xu H
Medicine (Baltimore); 2019 May; 98(22):e15786. PubMed ID: 31145302
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
20. The fetal safety of fluoxetine: a systematic review and meta-analysis.
Riggin L; Frankel Z; Moretti M; Pupco A; Koren G
J Obstet Gynaecol Can; 2013 Apr; 35(4):362-369. PubMed ID: 23660045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]